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Introduction
The discovery of Helicobacter pylori has revolution-
ised the management of peptic ulcer disease. In the
past, the majority of patients with ulcer disease were
treated with antisecretory drugs, and elective surgery
was necessary when medical therapy failed. Surgery
is now seldom needed. The success of eradication
therapy for H pylori in managing ulcer disease, has
further refined the indications for elective surgery and
has dramatically reduced the need for such operations.
Nevertheless, surgery has been effective in managing
ulcer disease when traditional antisecretory drugs have
failed.1 It is intriguing that surgery has been effective,
given that H pylori infection is the actual culprit.
The management of perforated peptic ulceration
has been controversial. Simple closure has been
associated with high ulcer recurrence rates of 30%
to 80%.2-5 Since acid has been considered the most
important cause of ulcer disease and ulcer recurrence,
concurrent acid-reduction surgery was advocated
for the emergency treatment of fit patients with a
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perforated duodenal ulcer to reduce the likelihood of
recurrent ulceration occurring.6,7 If H pylori, rather
than acid, is the cause of ulcer disease, acid-reduction
surgery may not be necessary at all.
The development of ulcer surgery
The first successful distal gastrectomy for gastric
cancer was performed by Billroth in 1881. This landmark
procedure was followed by a successful Billroth-I
gastrectomy performed by Rydygier for a benign
pyloric ulcer.8 Rydygier also introduced gastrojejunos-
tomy in the treatment of duodenal ulceration in 1884.
After Pavlov’s many experiments of vagotomy in
animals, Bircher reported the performance of what
appeared to be an incomplete vagotomy in 20 patients
with various gastric symptoms.9 Latarjet was also
widely acclaimed for his work on the vagal innerva-
tion of the stomach. In 1922, he reported the need to
add a drainage procedure, namely gastrojejunostomy,
after a vagotomy.10 Unfortunately, Latarjet never
formally confirmed that vagotomy was a successful
treatment for peptic ulcer disease.
During the 1920s, ulcers were generally thought
to be due to gastric stasis, and the good results achieved
by Latarjet were attributed to the concomitant gastro-
jejunostomy. It was not until the 1940s that Dragstedt
established that a truncal vagotomy helps heal duodenal
HKMJ Vol 5 No 2 June 1999      159
Helicobacter pylori and ulcer surgery
ulcers because it depresses gastric secretion.11 Sub-
sequently, the role of the antrum in gastric physiology
became better understood, and vagotomy with antrectomy
was shown to reduce gastric acid secretion the most.12
In fact, the ulcer recurrence rate after this procedure
has been reported to be as low as 1%.13
In the 1960s and 1970s, recognising the side effects
of truncal vagotomy, more selective types of vagotomy
(selective vagotomy, proximal gastric vagotomy, and
posterior truncal vagotomy with lesser curvature
seromyotomy) were introduced. The more selective
types of vagotomy, however, are reported to be associ-
ated with a higher ulcer recurrence rate of up to 15%.13
The advent of laparoscopic surgery in the late 1980s
is an important development in the history of surgery.
With its advantages of a shorter and less painful post-
operative course, shorter recovery times, earlier return
to work, reduced scarring, and preservation of abdomi-
nal strength, laparoscopic surgery has stimulated
interest in transforming previously established open
techniques into laparoscopic procedures. Various
laparoscopic acid-reduction procedures have been
developed.14 While there was great excitement about
the development of various laparoscopic procedures
for peptic ulcer disease, the eradication of H pylori
became an established treatment for peptic ulcer
disease in the early 1990s.15 As a result, the need for
elective surgery for peptic ulcer disease has markedly
decreased,13,16 although the exact extent of the reduc-
tion has not been documented. At the Department of
Surgery of the Queen Mary Hospital, an average of 36
elective operations to treat peptic ulcer disease were
being performed annually between 1989 and 1993.
From 1994 to 1998, however, an average of only three
such operations per year were performed (unpublished
data, 1999). Such a marked reduction (92%) has
been possible because the majority of patients with
ulcer disease were treated successfully with H pylori
eradication therapy.17
Patients in whom gastric outlet obstruction develops
as a result of established pyloric stenosis with fibrosis
and scarring are unlikely to respond to H pylori eradi-
cation therapy. Surgery is indicated in these patients
if they do not respond to conservative treatment. Since
most patients can now be treated with eradication
therapy, the incidence of recurrent ulceration and
scarring would be reduced in the long term. In future,
benign acquired pyloric stenosis may become rare.
Emergency operations are performed to treat ulcer
complications such as bleeding or perforation. The
advent of therapeutic endoscopy has dramatically
diminished the need for emergency surgery to treat
bleeding peptic ulcers.18 Nevertheless, an emergency
operation is still indicated when endoscopic therapy
fails—nowadays, such patients are usually frail and
elderly individuals who have multiple medical pro-
blems. While the judicious use of non-steroidal anti-
inflammatory drugs (NSAIDs) by elderly patients is
important, whether the use of NSAIDs that specifically
inhibit cyclo-oxygenase-2 helps reduce the occurrence
of gastro-intestinal complications is still unconfirmed.19,20
In contrast, recent studies of H pylori–related ulcer
haemorrhage have confirmed the significant value of
eradication therapy in reducing ulcer recurrence and
rebleeding, as compared with maintenance therapy
with an antisecretory drug.21,22 In addition, in patients
with a duodenal ulcer that has not bled before, eradica-
tion therapy has been shown to diminish the risk of the
future occurrence of ulcer bleeding.23
Ulcer surgery and H pylori infection
Acid used to be considered the most important cause
of duodenal ulcer. In the past, reduction of gastric acid
was the primary goal of drug or surgical treatment for
peptic ulcer disease. Surgery has been the standard
treatment option when medical therapy fails.1 If H pylori
infection is the cause of peptic ulcer disease, it would be
interesting to study the effect of surgery on the infection.
It would be unethical to subject a patient with H pylori–
related duodenal ulcer to surgery, and most recent
studies thus involve patients who had previous surgery
for ulcer disease. Published studies reveal that the
prevalence of H pylori infection remains high—at
approximately 80%—after vagotomy, but that the
prevalence may be less in patients whose vagotomy is
complete.24-26 Hence, a modest reduction of H pylori
infection following complete vagotomy could be due
to a reduction of gastric secretion. In contrast, the
prevalence of H pylori infection has been shown to be
markedly reduced—to approximately 50%—following
partial gastrectomy.26-29 Such a reduction could be
linked to the removal of distal stomach, which is the
usual site of infection. In addition, bile reflux, which
occurs especially after a Billroth-II reconstruction,
seems to have a bactericidal effect on H pylori.27,30
Of the surgical procedures for duodenal ulceration,
vagotomy with antrectomy has been known for years
to have one of the lowest ulcer recurrence rates.13
For decades, therefore, surgeons have been quite
unknowingly eradicating H pylori by removing its
favourite habitat (the antrum), thereby reducing gastric
secretion and subjecting the organism to bile.
160      HKMJ Vol 5 No 2 June 1999
Chu
Perforated duodenal ulceration and H pylori
infection
In the emergency management of perforated duodenal
ulceration, the addition of acid-reduction surgery has
been advocated to reduce the risk of recurrent ulcera-
tion,6,7 but closure with an omental patch remains
the standard treatment in many hospitals.31,32 As with
elective ulcer surgery, laparoscopic surgery has been
introduced for the treatment of perforated duodenal
ulceration. Because laparoscopy involves a longer
operating time compared with the conventional open
procedure, all laparoscopic techniques described
have involved simple closure without an additional
acid-reduction procedure.33-36 It is thus important to
evaluate whether simple closure is adequate for the
treatment of perforated duodenal ulceration.
Although the association between H pylori
infection and perforated duodenal ulcer is not totally
clear,37-40 it would be reasonable to suspect such an
association in a patient who is not taking NSAIDs. If
the ulcer is caused by H pylori, it would be adequate
to treat the perforation with simple closure, followed
by postoperative eradication therapy.
In the past, it was unclear why ulcers recurred in
some but not all patients after surgery for ulcer per-
foration; both acute and chronic duodenal ulcers may
recur after perforation.41 Gastric acid secretion and
serum gastrin levels do not predict ulcer recurrence
after simple closure.42 Having a young age, smoking,
and having a long interval after surgery, however,
are associated with recurrence.41,43 We recently stud-
ied 163 patients with a past history of surgery for
perforated duodenal ulcer to investigate whether or
not ulcer recurrence is related to H pylori infection.44
Patients who had taken NSAIDs were excluded.
There was a male preponderance (male to female
ratio, 5.3:1) in the group and the mean age was 55.9
years. An upper gastro-intestinal endoscopic exami-
nation was performed at a mean interval of 74.5
months (standard deviation, 7.1 months) from the
initial operation. H pylori testing was found to be
positive in 77 patients (47.2%). Recurrent duodenal
ulceration was found in 29 patients (17.8%).44
The results of univariate analysis have shown that
male gender, a history of recurrent epigastric pain,
a longer interval from initial surgery, and positive
H pylori status are significant factors associated with
recurrent duodenal ulceration. Other factors such as
age, smoking, additional acid-reduction surgery, and
the intake of H2-receptor antagonists were not found
to be associated with ulcer recurrence.44 Multivariate
analysis revealed male gender and positive H pylori
status to be independent factors associated with
recurrent duodenal ulcer.44 It is not known why male
gender is an independent factor in the recurrence.
In addition to H pylori infection, male gender has
also been found to be an independent risk factor
for duodenal ulcer disease or its relapse in Chinese
populations.45,46
Because of the current findings, we recommend
the performance of simple closure for perforated duo-
denal ulcer. Postoperatively, such patients should be
given maintenance therapy with antisecretory drugs
such as H2-receptor antagonists until their H pylori
status is known. We routinely perform gastroscopic
examination 2 months postoperatively to confirm
the healing of ulcers as well as to obtain biopsies to
determine an individual’s H pylori status. Eradication
therapy is recommended for any patient who is found
to be positive for H pylori.
Despite the success of H pylori eradication therapy
in the treatment of peptic ulcer disease, there remain
a number of conditions that need surgery. These con-
ditions can be subdivided into elective and emergency
indications for surgery (Box).
Conclusion
Subsequent to the identification of H pylori infec-
tion as a major cause of peptic ulcer disease, the
indications for surgery have been further refined.
More patients are spared from unnecessary surgery and
its unwanted sequelae. On the other hand, the decreased
Peptic ulcer conditions that require surgery*
Elective indications:
(1) persistent ulceration despite medical treatment in a
patient without H pylori infection;
(2) persistent ulceration in a patient who has H pylori in-
fection resistant to multiple attempts of eradication
therapy;
(3) persistent ulceration in a patient who could not
tolerate eradication therapy for H pylori infection;
(4) persistent ulceration despite successful eradicatio 6n of
H pylori infection (ie ulcer may be unrelated to
H pylori infection);
(5) ulcer scarring leading to gastric outlet obstruction
which could not be resolved with conservative
management.
Emergency indications:
(1) ulcer haemorrhage that could not be controlled endo-
scopically;
(2) recurrent ulcer haemorrhage despite initial success with
endoscopic haemostasis;
(3) ulcer perforation.
* Excludes patients who are taking NSAIDs
HKMJ Vol 5 No 2 June 1999      161
Helicobacter pylori and ulcer surgery
performance of elective ulcer surgery also poses an
issue for the new generation of general surgeons who
will have less exposure to ulcer surgery. Furthermore,
the success of endoscopic therapy for ulcer haemor-
rhage in the past two decades has also resulted in a
significant drop in the number of emergency opera-
tions for bleeding ulcers. The most frequent indica-
tion for surgery to treat ulcer disease now is perforation.
Duodenal ulcer perforation is currently managed with
a simple closure, which is usually not technically
demanding. Complicated ulcer disease may require
the attention of the ‘older generation’–general surgeon
or specialist care in the future.
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